Vast Therapeutics
Company profile on P2PMarketData. Vast Therapeutics is a biotechnology company based in Morrisville, United States, founded in 2017. It has raised $604.8K through crowdfunding on StartEngine.
Vast Therapeutics is a biotechnology company focused on developing treatments for chronic respiratory diseases. The company's lead product candidate, ALX1, has received clearance from the FDA to begin Phase 1 clinical trials. Vast Therapeutics was founded in 2017 and is headquartered in Morrisville, North Carolina.
Frequently asked questions about Vast Therapeutics
How much funding has Vast Therapeutics raised?
Vast Therapeutics has raised $604.8K through crowdfunding across 1 round tracked by P2PMarketData, from 118 investors.
What is Vast Therapeutics' valuation?
Vast Therapeutics had an indicative valuation of $49.8M in its 2024 funding round.
What is Vast Therapeutics' revenue?
Vast Therapeutics reported revenue of $227.6K for fiscal year 2024.
Is Vast Therapeutics profitable?
No. Vast Therapeutics reported a net loss of $6.1M for fiscal year 2024.
How many employees does Vast Therapeutics have?
Vast Therapeutics reported 7 employees for fiscal year 2024.
When was Vast Therapeutics founded?
Vast Therapeutics was founded in April 2017.
Where is Vast Therapeutics based?
Vast Therapeutics is headquartered in Morrisville, North Carolina, United States, and is incorporated in Delaware, United States.
What industry is Vast Therapeutics in?
Vast Therapeutics operates in the Biotechnology industry within the Healthcare sector.